-+ 0.00%
-+ 0.00%
-+ 0.00%

Everest Medicines board to review interim results for six months ended June 30, 2026

PUBT·08/05/2026 09:03:39
Listen to the news
Everest Medicines board to review interim results for six months ended June 30, 2026
  • Everest Medicines will hold a board meeting on Aug. 18, 2026 to review interim results for the six months ended June 30, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260805-12273227), on August 05, 2026, and is solely responsible for the information contained therein.